Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons

Annals of the New York Academy of Sciences

Volumn 805, Issue , 1996, Pages 270-277

  Banks, William A ^b   Uchida, Daigaku ^a   Arimura, Akira ^a   Somogyvári Vigh, Aniko ^a   Shioda, Seiji ^a  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONFERENCE PAPER; HIPPOCAMPUS; ISCHEMIA; NONHUMAN; PROTEIN TRANSPORT;

EID: 0030453730     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17489.x     Document Type: Conference Paper

References (50)

1. MIYATA, A., A. ARIMURA, R. R. DAHL, N. MINAMINO, A. UEHARA, L. JIANG, M. D. CULLER & D. H. COY. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164: 567-574.
2. MIYATA, A., L. JIANG, R. R. DAHL, C. KITADA, K. KUBO, M. FUJINO, N. MINAMINO & A. ARIMURA. 1990. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170: 643-648.
3. ARIMURA, A. 1992. Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research. Regul. Pept. 37: 287-303.
4. ARIMURA, A., A. SOMOGYVARI-VIGH, A. MIYATA, K. MIZUNO, D. H. COY & C. KITADA. 1991. Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes. Endocrinology 129: 2787-2789.
5. DEUTSCH, P. J., V. SCHADLOW & N. BARZILAI. 1993. 38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells. J. Neurosci. Res. 35: 312-320.
6. DICICCO-BLOOM, E. & P. J. DEUTSCH. 1992. Pituitary adenylate cyclase activating polypeptide (PACAP) potently stimulates mitosis. Neuritogenesis and survival in cultures of rat sympathetic neuroblasts. Regul. Pept. 37: 319.
7. DEUTSCH, P. J. & Y. SUN. 1992. The 38-amino acid form of pituitary adenylate cyclaseactivating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem. 267: 5108-5113.
8. MORIO, H., I. TATSUNO, T. TANAKA, D. UCHIDA, A. HIRAI, Y. TAMURA & Y. SAITO. 1996. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neurotrophic factor for cultured rat cortical neurons. Ann. N.Y. Acad. Sci. This volume.
9. ARIMURA, A., A. SOMOGYVARI-VIGH, C. WEILL, R. C. FIORE, I. TATSUNO, V. BAY & D. E. BRENNEMAN. 1994. PACAP functions as a neurotrophic factor. Ann. N.Y. Acad. Sci. 739: 228-243.
10. ARIMURA, A. 1993. Receptors for pituitary adenylate cyclase activating polypeptide: Comparison with vasoactive intestinal peptide receptors. Trends Endocrinol. Metab. 3: 288-294.
11. BRENNEMAN, D. E., E. A. NEALE, G. A. FOSTER, S. W. D'AUTREMONT & G. L. WESTBROOK. 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104: 1603-1610.
12. 125I]N-Tyr-delta sleepinducing peptide crosses the blood-brain barrier by a non-competitive mechanism. Brain Res. 301: 201-207.
13. BANKS, W. A., A. J. KASTIN, D. H. COY & E. ANGULO. 1986. Entry of DSIP peptides into dog CSF: Role of physicochemical and pharmacokinetic parameters. Brain Res. Bull. 17: 155-158.
14. MILLER, L. H., B. A. TURNBULL, A. J. KASTIN & D. H. COY. 1986. Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier. Sleep (Rochester) 9: 80-84.
15. 1-28 (Alzheimer's disease protein). Brain Res. Bull. 27: 819-823.
16. WILSON, J. F. 1988. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin. Psychopharmacology (Berlin) 96: 262-266.
17. BANKS, W. A., A. J. KASTIN, V. AKERSTROM & J. B. JASPAN. 1993. Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis. Am. J. Physiol. 264: E723-E729.
18. MANESS, L. M., W. A. BANKS, M. B. PODLISNY, D. J. SELKOE & A. J. KASTIN. 1994. Passage of human amyloid β-protein 1-40 across the murine blood-brain barrier. Life Sci. 21: 1643-1650.
19. BANKS, W. A. & A. J. KASTIN. 1984. A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides. Pharmacol. Biochem. Behav. 21: 943-946.
20. BANKS, W. A., A. J. KASTIN, A. J. FISCHMAN, D. H. COY & S. L. STRAUSS. 1986. Carriermediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am. J. Physiol. 251: E477-E482.
21. BANKS, W. A. & A. J. KASTIN. 1990. Editorial Review: Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259: E1-E10.
22. BANKS, W. A., A. J. KASTIN & E. A. MICHALS. 1987. Tyr-MIF-1 and met-enkephalin share a saturable blood-brain barrier transport system. Peptides 8: 899-903.
23. BANKS, W. A., A. J. KASTIN, A. HORVATH & E. A. MICHALS. 1987. Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse. J. Neurosci. Res. 18: 326-332.
24. TSUJI, A., I. TAMAI, A. SAKATA, Y. TENDA & T. TERASAKI. 1993. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46: 1096-1099.
25. YAO, C. Z., J. ISHIZUKA, C. M. TOWNSEND & J. C. THOMPSON. 1993. Successful intracere-broventricular allotransplantation of parathyroid tissue in rats without immunosuppression. Transplantation 55: 251-253.
26. CLARK, R. G., P. M. JONES & I. C. A. F. ROBINSON. 1983. Clearance of vasopressin from cerebrospinal fluid to blood in chronically cannulated Brattleboro rats. Neuroendocrinology 37: 242-247.
27. 1]-Peptide T-amide is transported from blood to brain by a saturable system. Brain Res. Bull. 19: 629-633.
28. ZLOKOVIC, B. V., M. B. SEGAL, H. DAVSON & R. M. JANKOV. 1988. Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier. Peptides 9: 533-538.
29. BAURA, G. D., D. M. FOSTER, D. PORTE, JR., S. E. KAHN, R. N. BERGMAN, C. COBELLI & M. W. SCHWARTZ. 1993. Saturable transport of insulin from plasma into the central nervous system of dogs m vivo: A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92: 1824-1830.
30. KANNAN, R., J. F. KUHLENKAMP, M. OOKHTENS & N. KAPLOWITZ. 1992. Transport of glutathione at blood-brain barrier of the rat: Inhibition by glutathione analogs and agedependence. J. Pharmacol. Exp. Ther, 263: 964-970.
31. TERASAKI, T., Y. DEGUCHI, H. SATO, K. HIRAI & A. TSUJI. 1991. In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood-brain barrier: An application of brain microdialysis. Pharmacol. Res. (NY) 8: 815-820.
32. BANKS, W. A., A. J. KASTIN, W. HUANG, J. B. JASPAN & L. M. MANESS. 1996. Leptin enters the brain by a saturable system independent of insulin. Peptides 17: 305-311.
33. BANKS, W. A. & A. J. KASTIN. 1994. Opposite direction of transport across the bloodbrain barrier for Tyr-MIF-1 and MIF-1: Comparison with morphine. Peptides 15: 23-29.
34. PRESTON, E. & I. HYNIE. 1991. Transfer constants for blood-brain barrier permeation of the neuroexcitatory shellfish toxin, domoic acid. Can. J. Neurol. Sci. 18: 39-44.
35. 1-38 across the blood-brain barrier. J. Pharmacol. Exp. Ther. 267: 690-696.
36. BLASBERG, R. G., J. D. FENSTERMACHER & C. S. PATLAK. 1983. Transport of α-aminoisobu-tyric acid across brain capillary and cellular membranes. J. Cereb. Blood Flow Metab. 3: 8-32.
37. PATLAK, C. S., R. G. BLASBERG & J. D. FENSTERMACHER. 1983. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3: 1-7.
38. PULSINELLI, W. A. & A. M. BUCHNAN, M. D. GINSBERG & W. D. DIETRICH, EDS. 1989. The utility of animal ischemia models in predicting pharmacotherapeutic response in the clinical setting. In Cerebrovascular Diseases. Raven Press. New York. 87-91.
39. ZOLA-MORGAN, S., L. R. SQUIRE & D. G. AMARAL. 1986. Human amnesia and the medial temporal region: Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J. Neurosci. 6: 2950-2967.
40. NITATORI, T., N. SATO, S. WAGURI, Y. KARASAWA, H. ARAKI, K. SHIBANAI, E. KOMINAMI & Y. UCHIYAMA. 1995. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15: 1001-1011.
41. BAR-JOSEPH, A., Y. BERKOVITCH, J. ADAMCHIK & A. BIEGON. 1994. Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils. Mol. Chem. Neuropathol. 23: 125-135.
42. WEN, T. C., S. MATSUDA, H. YOSHIMURA, T. KAWABE & M. SAKANAKA. 1995. Ciliary neurotrophic factor prevents ischemia-induced learning disability and neuronal loss in gerbils. Neurosci. Lett. 191: 55-58.
43. BANKS, W. A. & A. J. KASTIN, P. D. GARZONE, W. A. COLBURN & M. MOKOTOFF, Eds. 1991. Regulation of the passage of peptides across the blood-brain barrier. In Pharmacokinetics and Pharmacodynamics, Vol. 3, Peptides, Peptoids, and Proteins. Harvey Whitney Books. Cincinnati. 147-153.
44. SCHWARTZ, R. D., X. Yu, M. R. KATZMAN, D. M. HAYDEN-HIXSON & J. M. PERRY. 1995. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J. Neurosci. 15: 529-539.
45. SHNAIB, A., D. TRULOVE, M. S. IJAZ, R. KANLHAN & J. KARLA. 1995. The effect of postischemic hypothermia following repetitive cerebral ischemia in gerbils. Neurosci. Lett. 186: 165-168.
46. JOHNSON, E. M. J. & T. L. DECKWERTH. 1993. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16: 31-46.
47. PECHAN, P. A., T. YOSHIDA, N. PANAHIAN, M. A. MOSKOWITZ & X. O. BREAKEFIELD. 1995. Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat. Neuroreport 6: 669-672.
48. BECK, T., D. LINDHOLM, E. CASTREN & A. WREE. 1994. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14: 689-692.
49. MASUO, Y., N. SUZUKI, H. MATSUMOTO, F. TOKITO, Y. MATSUMOTO, M. TSUDA & M. FUJINO. 1993. Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Brain Res. 602: 57-63.
50. PALKOVITS, M., A. SOMOGYVARI-VIGH & A. ARIMURA. 1995. Concentration of pituitary adenylate cyclase activating polypeptide (PACAP) in human brain nuclei. Brain Res. 699: 116-120.